- Report
- July 2024
- 125 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- October 2024
- 199 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 507 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 620 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 93 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 179 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- March 2025
- 182 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- December 2024
- 175 Pages
Global
From €3820EUR$4,000USD£3,195GBP
- Report
- November 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- September 2024
- 175 Pages
Global
From €3820EUR$4,000USD£3,195GBP
- Report
- September 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more